Dexcom joins the FDA’s digital health pilot program to accelerate innovative medical technologies with real-world...
Explore the latest breast cancer treatment developments and the challenges of sequencing antibody-drug conjugates to...
Bispecific antibodies are emerging immunotherapy for relapsed lymphoma and leukemia, offering a viable option when...
Bispecific therapy program by American Oncology Network offers safe outpatient dosing guidelines for community clinics,...
Heart failure management is shifting as pharmacists take on a larger role. Discover how they...
Proton pump inhibitors may reduce the benefit of durvalumab consolidation after chemoradiotherapy for unresectable stage...
President Trump directs CMS to allocate $10 billion for rural health transformation under the One...
New data on schizophrenia treatment options with subcutaneous olanzapine formulation show promise for people with...
Medicare introduces a $50 monthly copay for GLP-1 weight-loss drugs, offering affordable access to eligible...
FDA approves Leqembi home administration. Learn about the new starting dosage regimen for subcutaneous lecanemab...